This literature review discusses the theoretical and practical aspects of using exogenous phosphocreatine in patients with cardiovascular disorders.
Exogenous phosphocreatine use in cardiovascular disorders remains investigational; leaves open the need for randomized trials.
Goal of the review: to review theoretical and practical aspects of using exogenous phosphocreatine in the patients with cardio-vascular disorders in various clinical situations, given that phospho-transporting system disorders are the one of pathogenic elements responsible for reduction of cardiac pumping ability.
No takes yet. Share an insight, caveat, or question.
Ломиворотов et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: